Literature DB >> 15691594

Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights.

Homero Rubbo1, Valerie O'Donnell.   

Abstract

Nitric oxide (*NO) is a free radical species that diffuses and concentrates in the hydrophobic core of low-density lipoprotein (LDL) to serve as a potent antioxidant. Peroxynitrite, the product of the diffusion-limited reaction between *NO and superoxide anion, as well as lipoxygenase, represent relevant mediators of oxidative modifications in LDL. The focus of this review is the analysis of interactions between *NO, peroxynitrite and lipoxygenase during LDL oxidation, which are relevant in the development of the early steps as well as progression of atherosclerosis. The role of CO2 to redirect peroxynitrite reactivity in LDL, as well as the lipophilic antioxidant sparing actions of *NO, ascorbate and CO2 is also analyzed. In this context, the effects of novel potential pharmacological strategies against atherosclerosis such as Mn(III)porphyrins will be discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691594     DOI: 10.1016/j.tox.2004.11.019

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  18 in total

Review 1.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

2.  Role of caffeic acid phenethyl ester on mitomycin C induced clastogenesis: analysis of chromosome aberrations, micronucleus, mitotic index and adenosine deaminase activity in vivo.

Authors:  Ghassan Mohammad Sulaiman
Journal:  J Appl Genet       Date:  2012-03-02       Impact factor: 3.240

Review 3.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 4.  Oxidative stress as a mediator of cardiovascular disease.

Authors:  Maqsood M Elahi; Yu Xiang Kong; Bashir M Matata
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

5.  Abnormalities of Selected Trace Elements in Patients with Coronary Artery Disease.

Authors:  Asim Ilyas; Munir H Shah
Journal:  Acta Cardiol Sin       Date:  2015-11       Impact factor: 2.672

Review 6.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Cardiovasc Drug Rev       Date:  2007

7.  The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study.

Authors:  Jian-Jin Tang; Ming-Wei Wang; En-zhi Jia; Jian-Jun Yan; Qi-Ming Wang; Jun Zhu; Zhi-Jian Yang; Xiang Lu; Lian-sheng Wang
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

8.  Potential Benefits of Peroxynitrite.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Open Pharmacol J       Date:  2008

Review 9.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.